Carboplatin 150 mg Injection (Carbotero)

Carboplatin 150 mg injection  is a prescription-only oncology injectable formulated as a sterile solution for intravenous administration after dilution. Marketed under the brand name Carbotero, this product contains Carboplatin, a platinum-based antineoplastic agent widely used in regulated oncology treatment frameworks. Carboplatin 150 mg injection is manufactured for hospital and institutional use and is supplied strictly for international export to licensed pharmaceutical distributors, hospitals, and cancer treatment centers. AmeriDrugs does not offer this product for retail sale or direct patient use.

Active Ingredient

• Carboplatin – 150 mg per vial (150 mg/15 mL)
  Carboplatin is a platinum coordination compound used under approved oncology indications and administered under medical supervision.

Therapeutic Use

From an informational and regulatory perspective, Carboplatin 150 mg injection is used in approved oncology treatment settings for various solid tumors, as defined by regulatory authorities in the importing country. This information is provided solely for product identification and international trade clarity. AmeriDrugs does not provide medical advice, treatment protocols, or patient-level guidance related to Carboplatin 150 mg injection.

Dosage Form

• Sterile injectable solution

• Single-dose vial

• Intended for intravenous use after dilution by qualified healthcare professionals

• Preparation and administration decisions are determined exclusively by licensed medical personnel in accordance with local regulations

Quality & Manufacturing Standards

Carboplatin 150 mg injection (Carbotero) is manufactured in GMP-compliant facilities operating under validated pharmaceutical quality management systems. Manufacturing includes sterile processing, in-process controls, and finished product testing to ensure identity, strength, purity, and consistency aligned with international export standards for Carboplatin 150 mg injection.

Packaging Information

• Single-dose vial containing 150 mg/15 mL

• Pharmaceutical-grade vial with rubber stopper and flip-off seal

• Export-grade secondary packaging for international shipping

• Labeling compliant with prescription injectable oncology medicine regulations

Target Buyers

This product is intended exclusively for supply to:

• Licensed pharmaceutical importers and distributors

• Hospitals and oncology treatment centers

• Government and private cancer care institutions

• Authorized healthcare procurement agencies

It is not intended for retail pharmacies, online consumer sales, or direct patient distribution.

Regulatory & Compliance Note

Carboplatin 150 mg injection (Carbotero) is a prescription-only oncology injectable. Importation, storage, distribution, and use must comply with the pharmaceutical laws, injectable drug regulations, and oncology approvals of the destination country. Buyers are responsible for ensuring regulatory compliance within their jurisdiction. AmeriDrugs operates solely as an export-focused pharmaceutical supplier and does not promote Carboplatin 150 mg injection for self-medication or any non-regulated use.